236 related articles for article (PubMed ID: 29117645)
21. 4-Phenylbutyric acid reduces mutant-TGFBIp levels and ER stress through activation of ERAD pathway in corneal fibroblasts of granular corneal dystrophy type 2.
Choi SI; Lee E; Jeong JB; Akuzum B; Maeng YS; Kim TI; Kim EK
Biochem Biophys Res Commun; 2016 Sep; 477(4):841-846. PubMed ID: 27373828
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of TGFBIp expression by lithium: implications for TGFBI-linked corneal dystrophy therapy.
Choi SI; Kim BY; Dadakhujaev S; Jester JV; Ryu H; Kim TI; Kim EK
Invest Ophthalmol Vis Sci; 2011 May; 52(6):3293-300. PubMed ID: 21310903
[TBL] [Abstract][Full Text] [Related]
23. Differential expression and processing of transforming growth factor beta induced protein (TGFBIp) in the normal human cornea during postnatal development and aging.
Karring H; Runager K; Valnickova Z; Thøgersen IB; Møller-Pedersen T; Klintworth GK; Enghild JJ
Exp Eye Res; 2010 Jan; 90(1):57-62. PubMed ID: 19788893
[TBL] [Abstract][Full Text] [Related]
24. Composition and proteolytic processing of corneal deposits associated with mutations in the TGFBI gene.
Karring H; Runager K; Thøgersen IB; Klintworth GK; Højrup P; Enghild JJ
Exp Eye Res; 2012 Mar; 96(1):163-70. PubMed ID: 22155582
[TBL] [Abstract][Full Text] [Related]
25. Inhibitory Effect of Tranilast on Transforming Growth Factor-Beta-Induced Protein in Granular Corneal Dystrophy Type 2 Corneal Fibroblasts.
Kim TI; Lee H; Hong HK; Kim KS; Choi SI; Maeng YS; Kim EK
Cornea; 2015 Aug; 34(8):950-8. PubMed ID: 26020822
[TBL] [Abstract][Full Text] [Related]
26. Involvement of TGF-{beta} receptor- and integrin-mediated signaling pathways in the pathogenesis of granular corneal dystrophy II.
Choi SI; Yoo YM; Kim BY; Kim TI; Cho HJ; Ahn SY; Lee HK; Cho HS; Kim EK
Invest Ophthalmol Vis Sci; 2010 Apr; 51(4):1832-47. PubMed ID: 19933198
[TBL] [Abstract][Full Text] [Related]
27. Effect of osmolytes on in-vitro aggregation properties of peptides derived from TGFBIp.
Venkatraman A; Murugan E; Lin SJ; Peh GSL; Rajamani L; Mehta JS
Sci Rep; 2020 Mar; 10(1):4011. PubMed ID: 32132634
[TBL] [Abstract][Full Text] [Related]
28. Biochemical properties and aggregation propensity of transforming growth factor-induced protein (TGFBIp) and the amyloid forming mutants.
Lakshminarayanan R; Chaurasia SS; Murugan E; Venkatraman A; Chai SM; Vithana EN; Beuerman RW; Mehta JS
Ocul Surf; 2015 Jan; 13(1):9-25. PubMed ID: 25557343
[TBL] [Abstract][Full Text] [Related]
29. Fibril Core of Transforming Growth Factor Beta-Induced Protein (TGFBIp) Facilitates Aggregation of Corneal TGFBIp.
Sørensen CS; Runager K; Scavenius C; Jensen MM; Nielsen NS; Christiansen G; Petersen SV; Karring H; Sanggaard KW; Enghild JJ
Biochemistry; 2015 May; 54(19):2943-56. PubMed ID: 25910219
[TBL] [Abstract][Full Text] [Related]
30. Mutation-Induced Deamidation of Corneal Dystrophy-Related Transforming Growth Factor β-Induced Protein.
Nielsen NS; Juhl DW; Poulsen ET; Lukassen MV; Poulsen EC; Risør MW; Scavenius C; Enghild JJ
Biochemistry; 2017 Dec; 56(49):6470-6480. PubMed ID: 29140698
[TBL] [Abstract][Full Text] [Related]
31. Identifying and categorizing compounds that reduce corneal transforming growth factor beta induced protein levels: a scoping review.
Sciriha GG; Sultana J; Borg J
Expert Rev Clin Pharmacol; 2022 Dec; 15(12):1423-1442. PubMed ID: 36308770
[TBL] [Abstract][Full Text] [Related]
32. Systemic investigation of keratoepithelin deposits in TGFBI/BIGH3-related corneal dystrophy.
El Kochairi I; Letovanec I; Uffer S; Munier FL; Chaubert P; Schorderet DF
Mol Vis; 2006 May; 12():461-6. PubMed ID: 16710170
[TBL] [Abstract][Full Text] [Related]
33. Purification and structural characterization of transforming growth factor beta induced protein (TGFBIp) from porcine and human corneas.
Andersen RB; Karring H; Møller-Pedersen T; Valnickova Z; Thøgersen IB; Hedegaard CJ; Kristensen T; Klintworth GK; Enghild JJ
Biochemistry; 2004 Dec; 43(51):16374-84. PubMed ID: 15610032
[TBL] [Abstract][Full Text] [Related]
34. TGFBI gene mutations in corneal dystrophies.
Kannabiran C; Klintworth GK
Hum Mutat; 2006 Jul; 27(7):615-25. PubMed ID: 16683255
[TBL] [Abstract][Full Text] [Related]
35. Structural and Functional Implications of Human Transforming Growth Factor β-Induced Protein, TGFBIp, in Corneal Dystrophies.
García-Castellanos R; Nielsen NS; Runager K; Thøgersen IB; Lukassen MV; Poulsen ET; Goulas T; Enghild JJ; Gomis-Rüth FX
Structure; 2017 Nov; 25(11):1740-1750.e2. PubMed ID: 28988748
[TBL] [Abstract][Full Text] [Related]
36. A clinical and histopathologic examination of accelerated TGFBIp deposition after LASIK in combined granular-lattice corneal dystrophy.
Aldave AJ; Sonmez B; Forstot SL; Rayner SA; Yellore VS; Glasgow BJ
Am J Ophthalmol; 2007 Mar; 143(3):416-9. PubMed ID: 17317389
[TBL] [Abstract][Full Text] [Related]
37. Effect of position-specific single-point mutations and biophysical characterization of amyloidogenic peptide fragments identified from lattice corneal dystrophy patients.
Anandalakshmi V; Murugan E; Leng EGT; Ting LW; Chaurasia SS; Yamazaki T; Nagashima T; George BL; Peh GSL; Pervushin K; Lakshminarayanan R; Mehta JS
Biochem J; 2017 May; 474(10):1705-1725. PubMed ID: 28381645
[TBL] [Abstract][Full Text] [Related]
38. Downregulation of IL-7 and IL-7R Reduces Membrane-Type Matrix Metalloproteinase 14 in Granular Corneal Dystrophy Type 2 Keratocyte.
Kim SY; Yeo A; Noh H; Ji YW; Song JS; Kim HC; Kim LK; Lee HK
Invest Ophthalmol Vis Sci; 2018 Nov; 59(13):5693-5703. PubMed ID: 30489629
[TBL] [Abstract][Full Text] [Related]
39. Impaired Autophagic Degradation of Transforming Growth Factor-β-Induced Protein by Macrophages in Lattice Corneal Dystrophy.
Han J; Zhang M; Lin HY; Huang FY; Lin YY; Tan GH; Zheng ZY
Invest Ophthalmol Vis Sci; 2019 Mar; 60(4):978-989. PubMed ID: 30884524
[TBL] [Abstract][Full Text] [Related]
40. A unique TGFBI protein in granular corneal dystrophy types 1 and 2.
Han YP; Sim AJ; Vora SC; Huang AJ
Curr Eye Res; 2012 Nov; 37(11):990-6. PubMed ID: 22746317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
